Perhaps the Obama administration, which owes a debt of gratitude to the free-spending trial bar, will be more sympathetic.

FORBES: AMA To Geithner: No Lawyer Tax Breaks!

If the trial bar is successful in the current case, this could be the next big area of product liability against drug makers.

FORBES: A New Wave Of Product Liability Against Drug Makers? Tomorrow The Supreme Court Decides

Previously, the trial bar could use the testimony of people who did not have the background to speak knowledgeably about the subject at hand.

FORBES: Fact and Comment